The German pharmaceutical company Bayer will invest 7.5 billion pesos (358 million dollars or 325.7 million euros) in Mexico over the next three years through its three divisions: pharmaceutical, consumer and agricultural, reported this Thursday the general director of the company in Mexico, Manuel Bravo.
“Our history began with only 5 people and today we are the twelfth most important market for the company globally, which is why we are going to continue betting on the growth of Mexico today and for the next 100 years,” the manager said in a statement.
He added that the company has focused on science and innovation to create medical therapies, self-care products, promote the field and “thus contribute to improving the quality of life of Mexicans.”
He pointed out that in 2021, Bayer allocated 2.5 billion pesos (119 million dollars) to Mexico, of which 55% was allocated to research and development, so this investment is expected to grow in the coming years.
Bravo recalled that after 100 years in the country, the firm has more than 5,000 employees, 8 production plants and 10 research centers.
He reiterated that Bayer, in its pharmaceutical division, develops more effective and accessible innovative prescription drugs, which seek to change the reality of medicine in Mexico and the world for therapeutic areas such as cardiology, oncology, gynecology and ophthalmology, as well as cell therapy. and gene.
The division currently has a portfolio of more than 50 products, and expects in the coming months the approval, in Mexico, of another 5 new molecules for cancer, heart care and hemophilia.
While in its consumer division it offers health care products to relieve headaches, upset stomachs and strengthen the immune system.
Finally, with its agricultural division, it promotes and promotes sustainable agriculture through technology and innovation.
The company specified that the division is the market leader in corn, sorghum and cotton seeds, with a production of 2.5 million bags of corn seed and 15,000 kilos of vegetable seeds per year that are distributed globally.
To date, in Mexico the company has already reached 2 million small producers with training and tailored solutions; the goal is to reach 3.5 million by 2030.
“In the coming years we will put all our effort into materializing our vision in the country: Health for all, no one hungry,” concluded Bravo.